ExcelFin收购公司。

2023年6月28日,

照片:马塞洛Leal / Unsplash.com 6月28日,2023中国医疗设备开发商Baird医疗已同意在美国上市与特殊目的收购公司通过企业合并(SPAC) ExcelFin收购集团,根据公告。合并后的公司将经营Baird医疗投资控股拟议的交易一旦完成,将在纳斯达克股票BDMD下交易。拟议的交易代表发起股权价值3亿美元的贝尔德医疗和一个隐含形式上的企业价值约3.7亿美元的合并后的公司。该交易预计将在2023年第四季度,完成受到监管机构和股东的批准,每公告。事务包含一个1500万美元最低收现金状况。ExcelFin大财富资本、赞助会员,已同意购买约880万美元的贝尔德医疗目前的债务从中银国际投资有限公司,Baird目前的优先股股东之一。总部在广州,中国,Baird医疗是微波消融的开发商和供应商(MWA)医疗设备。这些设备已经彻底改变了在中国治疗多种肿瘤类型,包括甲状腺结节和乳腺肿块。Frost & Sullivan的报告,Baird医疗目前在这些领域拥有35%的市场份额。中国的整体医疗设备市场目前的估值约为1460亿美元,预计每年增长大约7.8%在2023年和2026年之间。 Since its founding in 2012, Baird Medical has utilised an extensive sales and distribution network spanning over 100 distributors to penetrate 430 hospitals across China, including over 250 Grade III hospitals. “We believe ExcelFin’s partnership and international connections will provide us with the necessary resources to further expand our presence in the global market, accelerate our growth trajectory, and continue delivering innovative medical solutions to patients worldwide,” said Haimei Wu, founder and CEO of Baird Medical. SPACs, also known as blank cheque companies, raise capital via traditional IPOs for the purpose of acquiring a privately held company. A merger with the publicly traded SPAC provides a private company with a cheap and fast listing route. Early this month, TNL Mediagene , an Asian digital media company, has agreed to go public in the US through a business combination with special purpose acquisition company (SPAC) Blue Ocean Acquisition, according to an announcement.